Yashoda H. Barage

Dr. Yashoda H. Barage


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
YBYashoda H. Barage
Yashoda H. Barage
JLJaya Lakkakula
Jaya Lakkakula
ASArushi Sharma
Arushi Sharma
ARArpita Roy
Arpita Roy
Saad Saeed AlghamdiSaad Saeed Alghamdi
Saad Saeed Alghamdi
OAOsama Abdulaziz
Osama Abdulaziz
Food packaging industry is going through various scientific evolutions as per the preferences of the consumers along with the consumer trends. Current trends focus on not only protecting the food intelligently but also making it visually appealing to the consumer. In recent years, considerable attention is been given to replace nonbiodegradable materials with ecofriendly biodegradable composite material. Nanotechnology is flourishing and has proven to be a great incorporation to the packaging industry, as it can also overcome the drawbacks of the existing methods. Various nanomaterials have been explored and tested for manufacturing of packaging materials. In the present review, we discussed on current trends in food packaging and their drawbacks with respect to over consumption of plastic and how sustainable packaging is being implemented. Furthermore, nanotechnology is becoming a promising and widely used potential in food packaging industry along with nanomaterials currently being used such as zinc nanoparticles, polymer clay nanoparticles, and silver nanoparticles in food packaging. This information will broaden our current understanding on potential and problems associated with nanotechnology in food packaging.

2 December 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
PWP. P. Waifalkar
P. P. Waifalkar
DNDaegwon Noh
Daegwon Noh
PDPoorva Derashri
Poorva Derashri
YBYashoda H. Barage
Yashoda H. Barage
EOEunsoon Oh
Eunsoon Oh
Estradiol is known as one of the most potent estrogenic endocrine-disrupting chemicals (EDCs) that may cause various health implications on human growth, metabolism regulation, the reproduction system, and possibly cancers. The detection of these EDCs in our surroundings, such as in foods and beverages, is important to prevent such harmful effects on humans. Aptamers are a promising class of bio-receptors for estradiol detection due to their chemical stability and high affinity. With the development of aptamer technology, electrochemical aptasensing became an important tool for estradiol detection. This review provides detailed information on various technological interventions in electrochemical estradiol detection in solutions and categorized the aptasensing mechanisms, aptamer immobilization strategies, and electrode materials. Moreover, we also discussed the role of estradiol in human physiology and signaling mechanisms. The level of estradiol in circulation is associated with normal and diseased conditions. The aptamer-based electrochemical sensing techniques are powerful and sensitive for estradiol detection.

1 January 2014 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
PSPraveen Kishore Sahu
Praveen Kishore Sahu
PIPavithra S. Iyer
Pavithra S. Iyer
YBYashoda H. Barage
Yashoda H. Barage
KSKailas D. Sonawane
Kailas D. Sonawane
BCBalu A. Chopade
Balu A. Chopade
Relative quantification ofalgCgene expression was evaluated in the multidrug resistant strainAcinetobacter baumanniiAIIMS 7 biofilm (3 to 96 h, on polystyrene surface) compared to the planktonic counterparts. Comparison revealed differentialalgCexpression pattern with maximum 81.59-fold increase in biofilm cells versus 3.24-fold in planktonic cells (P<0.05). Expression levels strongly correlated with specific biofilm stages (scale of 3 to 96 h), coinciding maximum at initial surface attachment stage (9 h) and biofilm maturation stage (48 h). Cloning, heterologous expression, and bioinformatics analyses indicatedalgCgene product as the bifunctional enzyme phosphomannomutase/phosphoglucomutase (PMM/PGM) of ∼53 kDa size, which augmented biofilms significantly inalgCclones compared to controls (lackingalgCgene), further localized by scanning electron microscopy. Moreover, molecular dynamics analysis on the three-dimensional structure of PMM/PGM (simulated up to 10 ns) revealed enzyme structure as stable and similar to that inP. aeruginosa(synthesis of alginate and lipopolysaccharide core) and involved in constitution of biofilm EPS (extracellular polymeric substances). Our observation on differential expression pattern ofalgChaving strong correlation with important biofilm stages, scanning electron-microscopic evidence of biofilm augmentation taken together with predictive enzyme functions via molecular dynamic (MD) simulation, proposes a new basis ofA. baumanniiAIIMS 7 biofilm development on inanimate surfaces.

7 April 2019 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
RMRohan J. Meshram
Rohan J. Meshram
KBKamini T. Bagul
Kamini T. Bagul
SPShristi P. Pawnikar
Shristi P. Pawnikar
YBYashoda H. Barage
Yashoda H. Barage
BKBaban S. Kolte
Baban S. Kolte
RGRajesh Gacche
Rajesh Gacche
Flavonoids correspond to a major class of polyphenolic phytochemicals with flavone as major parent scaffold. This class of compounds is attributed with a very rich nutritional as well as therapeutic values. The present study focuses on a panel of 16 flavonoid molecules that are demonstrated to exhibit various bioactivities like anti-angiogenic, anti-inflammatory as well as possess antioxidant potential. The electronic basis of these bioactivities are rarely explored and structural basis of flavonoid induced cyclooxygenase (COX) inhibition has still remained an uncharted area. The current report thus focuses on providing an electronic explanation of these bioactivities using density functional theory based quantum chemical descriptors. We also attempt to provide a structure-activity relation model for COX by inhibition of these 16 flavonoids using molecular docking. Here we report molecular dynamics data from 16 Flavonoid-COX-2 complexes performed for 50 nano-seconds each that demonstrates key structural and dynamic aspects of flavonoid based COX inhibition in light of observed experimental facts. Interaction analysis and evaluation of side chain dynamics presented in current study are in well agreement with the empirical study and is hoped to pave new avenues towards design and development of COX-2 selective chemical agents.

6 November 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
YBYashoda H. Barage
Yashoda H. Barage
AKA. Karthic
A. Karthic
RBRohit Bavi
Rohit Bavi
NDNeetin Desai
Neetin Desai
RKRaj Kumar
Raj Kumar
KLKeun Woo Lee
Keun Woo Lee
The World Health Organization has declared COVID-19 as a global health emergency. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and highlights an urgent need for therapeutics. Here, we have employed a series of computer-aided drug repurposing campaign to discover inhibitors of RNA dependent RNA polymerase (RdRp) and Nsp15/EndoU. Subsequently, MD simulation has been performed to observe dynamic behavior of identified leads at the active site of RdRp and Nsp15. We successfully identified novel lead molecule such as Alectinib for RdRp while Naldemedine and Ergotamine for NSP15. These lead molecules were accommodated in the active site of the enzyme and stabilized by the networks of the hydrogen bond, pi type and hydrophobic interaction with key residues of either target. Interestingly, identified compounds show molecular mimicry in terms of molecular interactions with key residues of RdRp and Nsp15 essential for catalysis and substrate interaction. Previously, Alectinib, Naldemedine and Ergotamine were used as drug in different diseases might be repurposed against selected protein targets of COVID19. Finally, we propose that the identified inhibitors represent a novel lead molecule to design a more effective inhibitor to stop the progress of pathogen. Communicated by Ramaswamy H. Sarma

3 August 2022 in Polymers
Verified
Journal Article
Open access
PDF file
Kamini VelhalKamini Velhal
Kamini Velhal
YBYashoda H. Barage
Yashoda H. Barage
ARArpita Roy
Arpita Roy
JLJaya Lakkakula
Jaya Lakkakula
RYRamesh Yamgar
Ramesh Yamgar
Byong-Hun JeonByong-Hun Jeon
Byong-Hun Jeon
This review presented the unique characteristics of different types of cyclodextrin polymers by non-covalent host–guest interactions to synthesize an inclusion complex. Various cancers are treated with different types of modified cyclodextrins, along with the anticancer drug paclitaxel. PTX acts as a mitotic inhibitor, but due to its low dissolution and permeability in aqueous solutions, it causes considerable challenges for drug delivery system (DDS) designs. To enhance the solubility, it is reformulated with derivatives of cyclodextrins using freeze-drying and co-solvent lyophilization methods. The present supramolecular assemblies involve cyclodextrin as a key mediator, which is encapsulated with paclitaxel and their controlled release at the targeted area is highlighted using different DDS. In addition, the application of cyclodextrins in cancer treatment, which reduces the off-target effects, is briefly demonstrated using various types of cancer cell lines. A new nano-formulation of PTX is used to improve the antitumor activity compared to normal PTX DDS in lungs and breast cancer is well defined in the present review.